Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-27T11:05:44.292Z Has data issue: false hasContentIssue false
  • English
  • Français

Audit of out-patients on ‘higher dose’ antipsychotics

Published online by Cambridge University Press:  02 January 2018

John R. Taylor  and
Ian B. Cookson
John R. Taylor*
Affiliation:
North Mersey Community Trust Arundel House Resource Centre, Sefton General Hospital Smithdown Road, Liverpool L9 2JP
Ian B. Cookson
Affiliation:
North Mersey Community Trust Arundel House Resource Centre, Sefton General Hospital Smithdown Road, Liverpool L9 2JP
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Standards developed from the Royal College of Psychiatrists' consensus statement on the use of high-dose antipsychotics were audited. The baseline survey and two completed audit cycles are described showing improvement in the monitoring and management of out-patients on higher dose depot antipsychotics. Initially the main problem was poor attendance at hospital appointments. Practice was changed by (a) medical staff becoming more assertive and visiting non-attenders at home; (b) a phlebotomist visiting patients at home. Deinstitutionalisation has relocated many patients with chronic psychoses into the community, but services, including the ancillary services, have sometimes been slow to follow. This audit found that the most effective change was the provision of services to patients in their own home.

Type
Audit
Information
Psychiatric Bulletin , Volume 21 , Issue 7 , July 1997 , pp. 445 - 448
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

British Medical Association & Royal Pharmaceutical Society (1995) British National Formulary (BNF), Number 29. London: British Medical Association & The Pharmaceutical Press.Google Scholar
Committee on Safety of Medicines & Medicines Control Agency (1996) Drug-induced prolongation of the QT interval. Current Problems in Pharmacovigilance, 22, 2.Google Scholar
Cookson, I. B. (1987) The effect of a 50% reduction of Cis(z) – flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime. International Clinical Psychopharmacology, 2, 141–149.CrossRefGoogle ScholarPubMed
Foster, P. (1989) Neuroleptic equivalence. Pharmaceutical Journal, 290, 431–432.Google Scholar
Hirsh, S. R. & Barnes, T. R. E. (1994) Clinical use of high-dose neuroleptics. British Journal of Psychiatry, 164, 94–96.Google Scholar
Kane, J. M. (1994) The use of higher-dose antipsychotic medication. British Journal of Psychiatry, 164, 431–432.CrossRefGoogle ScholarPubMed
Krasucki, C. & McFarlane, F. (1996) Electrocardiograms. high-dose antipsychotic treatment and College guidelines. Psychiatric Bulletin, 20, 326–330.Google Scholar
Krawiecka, M., Goldberg, D. & Vaughan, M. (1977) A standardised psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica, 55, 299–308.Google Scholar
Thomas, H. L. (1994) Drugs, QT interval abnormalities and ventricular arrhythmias. Adverse Drug Reactions and Toxicological Reviews, 13, 77–102.Google Scholar
Thompson, C. (1994) The use of high-dose antipsychotic medication. British Journal of Psychiatry, 164, 448–458.Google Scholar
Warner, J. P., Slade, R. & Barnes, T. R. (1995) Change in antipsychotic prescribing practice. Psychiatric Bulletin, 19, 237–239.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.